TIAA CREF Investment Management’s Corbus Pharmaceuticals CRBP Stock Holding History

TIAA CREF Investment Management’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$692K	Hold	3,318	–	–	﹤0.01%	2478
2018 Q4	$581K	Hold	3,318	–	–	﹤0.01%	2506
2018 Q3	$751K	Sell	3,318 -209	-6%	-$33.8K	﹤0.01%	2549
2018 Q2	$534K	Sell	3,527 -614	-15%	-$112K	﹤0.01%	2760
2018 Q1	$758K	Buy	4,141 +286	+7%	+$64.2K	﹤0.01%	2569
2017 Q4	$821K	Buy	3,855 +9	+0.2%	+$1.93K	﹤0.01%	2559
2017 Q3	$825K	Sell	3,846 -173	-4%	-$33.8K	﹤0.01%	2614
2017 Q2	$760K	Buy	+4,019	New	+$788K	﹤0.01%	2674

Other funds holding CRBP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

TIAA CREF Investment Management's CRBP Position: Q1 2019 in Review

TIAA CREF Investment Management held its Corbus Pharmaceuticals (CRBP) position steady in Q1 2019 at 3,318 shares worth $692K. The position accounts for ﹤0.01% of the portfolio, ranked #2478.

TIAA CREF Investment Management first reported a position in CRBP in Q2 2017 and has held it in 8 quarters since. The position peaked at $825K in Q3 2017. 101 funds tracked by Wall St. Rank hold CRBP as of Q1 2019.

TIAA CREF Investment Management held 3,318 shares of Corbus Pharmaceuticals worth $692K as of Q1 2019.
TIAA CREF Investment Management left its Corbus Pharmaceuticals share count unchanged in Q1 2019.
Corbus Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2478 holding.
TIAA CREF Investment Management first reported a position in Corbus Pharmaceuticals in Q2 2017 and has held it in 8 quarters since.
TIAA CREF Investment Management's Corbus Pharmaceuticals position peaked at $825K in Q3 2017.
101 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.